JVJan Herman Veldink

Jan Herman Veldink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jan Herman Veldink has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Convergent genetic and functional evidence implicate KCND3 in Brugada Syndrome

    by Henan Liu, Arie O. Verkerk, Pierre Lindenbaum, Isabella Mengarelli, Fenna Tuijnenburg, Rezbieara P. Rahman, John Mauleekoonphairoj, Maarten Kooyman, Dominic Zimmerman, Estelle Baron, et al.

    Background: Dysfunction of the KCND3 -encoded K v 4.3 channel, which carries the transient outward potassium current ( I to ), has long been suspected to contribute to the pathophysiology of Brugada Syndrome (BrS). Although recent genome-wide association studies (GWAS) have implicated KCND3 , the role of rare variation in this gene remains uncertain and clinically unactionable. Methods: Genome sequencing was performed in 983 BrS probands from Europe and Thailand. Putative gain-of-function (GoF) rare variants in KCND3 identified in patients were functionally characterized by patch-clamp analysis of K v 4.3 current properties using a HEK293 cell heterozygous model. Biobank datasets were utilized to evaluate rare-common variant interaction at the KCND3 locus. Results: Eight BrS cases carried six different rare KCND3 variants which clustered at the K v 4.3 C-terminus, with terminal exon rare variants significantly enriched in cases versus study (p=0.004) and population (p=2.0e −6 ) controls. Four of the five KCND3 case variants studied demonstrated significant GoF effects versus wild-type and putative benign variants, including increased I to amplitude (p.Leu586Val, p.Ala634Thr) and slower inactivation (p.Gly600Arg, p.Ala654Thr, p.Ala634Thr). Analysis of p.Gly600Arg carriers in the UK Biobank and All of Us revealed a significant enrichment of the protective KCND3 expression-reducing allele of the GWAS lead single-nucleotide polymorphism rs12090194, suggesting a possible epistatic common-rare variant interaction modifies penetrance in carriers. Conclusions: GoF rare variants at the C-terminus of KCND3 are associated with BrS in a small proportion of cases. Determination of the rare and common variant status in BrS patients and their relatives may provide information about disease risk.

  • Open Access

    The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis

    by Paul Beele, Jan H. Veldink, Wouter van Rheenen

    Familial recurrence of amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD) is the clinical cornerstone for assuming Mendelian, monogenic inheritance which informs genetic testing, counselling and gene-discovery strategies in standard practice. Polygenic inheritance can lead to familial clustering of ALS, while pathogenic variants with reduced penetrance may present sporadically in small, modern-day pedigrees. As both rare genetic variants and polygenic disease contribute to the occurrence of ALS, the accuracy of a positive family history to predict the underlying genetic architecture remains unknown. Using growing knowledge of the genetic architecture of ALS, we designed the APECS simulator: a large-scale pedigree simulator using historical demographic parameters, unifying frameworks for monogenic and polygenic disease models. We simulated 1,000,000 three-generation pedigrees and modelled ALS, FTD, and other dementias under both inheritance models. For index patients with ALS, we examined the performance of proposed familial ALS (fALS) definitions to predict the underlying genetic architecture. Simulation results were benchmarked against real-world population estimates, over a wide range of demographic and genetic parameters. We assessed the phenocopy rate for monogenic index patients, defined as relatives with polygenic ALS or a pathogenic allele from a different ancestor. Finally, we illustrated the value of distant relatedness among apparently sporadic, but monogenic ALS patients. Simulations generated 55.3 million individuals, yielding 5,431 ALS-affected index patients (16.4% monogenic). The proposed criterion for ‘definite fALS’ (≥2 relatives with ALS among relatives within two degrees) had a 31.1% sensitivity, while falsely classifying 10.0% of ‘fALS’ as monogenic. The sensitivity of ‘definite fALS’ was improved to 43.3% when also considering relatives with FTD. Considering any type of dementia raised the false positive rate to 35.9%. In total, 5.3% of monogenic index patients had a phenocopy with ALS in relatives up to the third degree. Of seemingly sporadic monogenic index patients, 83.1% had distant relatives with ALS/FTD up to the fifth degree. A family history provides limited accuracy for inferring genetic architecture in ALS. Considering unspecified dementias in the family history reduces this accuracy, while adding definite FTD improves accuracy. Relying on traditional fALS criteria risks both missing cases for genetic testing and treatments, and falsely alarming families with polygenic ALS. Given the limited value of a family history and risk of phenocopies, routine genetic testing regardless of family history and systematic approaches for detecting distant relatedness will help to find known and novel genetic causes in ALS.

  • Open Access

    A Framework For Reconstruction And Analysis Of Extended Pedigrees From Large-Scale Genealogy And Archive Records

    by Daphne van Oosten, Paul Beele, Bi-Nan Wang, Sophie J. Plasmans, Nienke Wolthuis, Kyara van Den Berg, Maaike P. T. Blom, Myrte Meyjes, Nina D. van der Schoot, Hermieneke Vergunst-Bosch, et al.

    Genetic analyses in pedigrees remain a powerful approach to identify rare disease-causing variants. Reconstructing large enough pedigrees to yield sufficient power, however, still faces challenges. Clinical family histories are often incomplete, especially in late-onset diseases caused by genetic variants with incomplete penetrance. Amyotrophic lateral sclerosis (ALS) is such a disease with a disproportionately large contribution from rare variants with high but variable penetrance. Here, we present an open-source pipeline to reconstruct extended pedigrees from large-scale archive data dating back to ~1800, which we applied to a cohort of Dutch ALS patients carrying the C9orf72 hexanucleotide repeat expansion (HRE). Among 238 C9orf72 HRE carriers, 91 (38%) were members of an extended pedigree. Of these, 48 (53%) were clinically classified as sporadic ALS. In total, we identified 39 extended pedigrees including affected relatives up to the eighth degree of relatedness. Our approach increased the number of identified relationships by 2.5-fold compared with clinically obtained family histories, that typically missed relationships beyond the third degree. Genome-wide IBD analysis in pedigrees with ≥7 meioses fine-mapped the C9orf72 HRE to shared IBD segments spanning 10.2 - 127.0 centimorgans in 97% of pedigrees. This combined genealogical-genetic approach for large-scale reconstruction of extended pedigrees supports the reclassification of apparently sporadic cases, facilitates the discovery of new disease-causing variants in ALS, and is applicable to any disease with comparable genetic architecture.


  • Open Access

    Lessons from a systematic review of family-based studies in ALS

    by Bi-Nan Wang, Rick A. A. Van Der Spek, Justus D. A. M. Van Nispen Tot Sevenaer, Joke J. F. A. Van Vugt, Floor A. Munnik, Mark K. Bakker, Project MinE ALS Sequencing Consortium, Michael A. Van Es, Leonard H. Van Den Berg, Wouter Van Rheenen, et al.

    Amyotrophic lateral sclerosis (ALS) is a clinically and genetically heterogeneous disease with limited effective treatments. Although over 40 genes have been associated with ALS, a genetic cause re...

  • Tofersen treatment in respiratory onset amyotrophic lateral sclerosis and a variant of uncertain significance in SOD1; a case report

    by Sean W. Willemse, Koen C. Demaegd, Wouter Koole, Ruben P. A. van Eijk, Wouter van Rheenen, Jan H. Veldink, Leonard H. van Den Berg, Michael A. van Es


  • Diagnostic Revision From Primary Lateral Sclerosis to Amyotrophic Lateral Sclerosis

    by Eva M.J. de Boer, Sean W. Willemse, Jan H. Veldink, H. Stephan Goedee, Alexander F.J.E. Vrancken, Wouter van Rheenen, Henk-Jan Westeneng, Leonard H. van Den Berg, Michael A. van Es

    Primary lateral sclerosis (PLS) is defined as a pure upper motor neuron syndrome and is a diagnosis of exclusion, amyotrophic lateral sclerosis (ALS) being the most likely alternative diagnostic consideration. A minimum disease duration of 2 years is required for the diagnosis of PLS, after which patients are classified as probable PLS (P-PLS) and subsequently as definite PLS (D-PLS) after 4 years. Our aim is to apply the current diagnostic criteria to a population-based cohort and investigate which clinical characteristics are associated with a diagnostic revision to ALS. This cohort study included patients meeting the current diagnostic criteria for PLS retrospectively from the Dutch Motor Neuron Disease Registry. Diagnostic revision to ALS was based on clinical assessment, EMG findings according to the revised El Escorial Criteria, or if patients had died from disease progression within 4 years of disease onset. Clinical characteristics were compared for patients who underwent diagnostic revision with ALS vs true PLS. Subdistribution hazard ratios (SHRs) for characteristics associated with diagnostic revision were determined using Fine-Gray regression. We included 478 patients (median age of onset 59.3 years, interquartile range 50.8-67.0, 47.9% female), of whom 311 (65.1%) met criteria for P-PLS and 167 (34.9%) for D-PLS at diagnosis. Eighty-eight patients (18%) underwent diagnostic revision to ALS, 76 cases (86%) before 4 years of disease duration. Patients whose diagnosis was revised to ALS had higher median age at onset (63.4 vs 58.0 years, p = 5.20 × 10-4), more often had bulbar onset (38.6% vs 19.7%, p = 6.19 × 10-4), and faster progression (median ALS Functional Rating Scale-revised slope 0.43 vs 0.18, p = 6.05 × 10-11). The risk of diagnostic revision increased if progression rate was faster (SHR 3.08 95% CI 1.69-5.60, p = 2.35 × 10-4) and if diagnosis was P-PLS compared with D-PLS (SHR 3.08, 95% CI 1.65-5.74, p = 3.96 × 10-4). In our cohort, most diagnostic revisions from PLS to ALS were in patients with a disease duration of less than 4 years. Besides disease duration, a faster progression rate was associated with diagnostic revision from PLS to ALS. Adding progression rate to the current diagnostic criteria could increase accuracy and help identify patients at higher risk of developing ALS.


  • Open Access

    NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights

    by Shalini Agarwal, Syed Arif Abdul Rehman, Ivan M. Muñoz, Axel Knebel, Paul J. Hop, Robert Gourlay, Fiona Brown, Thomas Macartney, Iolo Squires, Jan H. Veldink, et al.

    Rare variants in NEK1, encoding a serine/threonine kinase, are amongst the most consistently implicated genetic contributors to amyotrophic lateral sclerosis (ALS), reported in approximately 2–3% of cases. Yet, whilst recent studies have characterised the cell biological consequences of NEK1 loss-of-function, the biochemical effects of ALS-associated missense variants on kinase activity have not been directly investigated. This distinction is mechanistically important, because missense alleles encode mutant proteins rather than simply reducing protein dosage. Here, we provide the most comprehensive cell-based phosphoproteomic map of NEK1 phosphorylation to date, identifying ten recurrent phosphorylation sites across independent expression and acquisition conditions. We experimentally assign pSer14, pThr156 and pSer418 as NEK1 autophosphorylation sites using kinase-dead controls, targeted extracted ion chromatogram analysis, phosphosite mutagenesis and phosphospecific antibodies. Leveraging activation-loop pThr156 as a readout of NEK1 activity, we assessed nine ALS-associated missense variants spanning the major functional regions of the protein. Amongst catalytic-domain variants, R261C produced the most robust reduction in pThr156 autophosphorylation, R232C produced a smaller reduction, and R232H increased pThr156; the basic-region variant, A313T, also showed a smaller reduction. Structural modelling provides a mechanistic framework for understanding these variant-specific effects. Our study establishes the first activity-based framework for functional classification of NEK1 missense variants, and provides direct evidence that ALS-associated missense variants can alter NEK1 autophosphorylation through a mechanism distinct from simple haploinsufficiency. The phosphospecific antibodies, isogenic cell lines and curated phosphoproteomic datasets generated here provide a community resource for future studies of NEK1 regulation, variant interpretation and therapeutic target validation.


  • Top Cited Papers
    Open Access

    Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis

    by Paul J. Hop, Maarten Kooyman, Brendan J. Kenna, Ramona A. J. Zwamborn, Kristel R. van Eijk, Yan Wang, Charlotte H. van Dijk, Erwin Bekema, Wouter van Rheenen, Paul Beele, et al.

    Amyotrophic lateral sclerosis (ALS) is a heritable disorder where rare variants with low-to-moderate penetrance are thought to dominate genetic risk. To identify such rare variants, we harmonized and analyzed exome data from 22 cohorts, totaling 17,919 individuals with ALS and 200,703 controls across discovery and replication phases. Rare variant analyses identified several new risk genes, with replication confirming association of YKT6 and supporting HTR3C , GBGT1 and KNTC1 . We also provide strong, independent validation for genes with limited previous evidence: ARPP21 , DNAJC7 and CFAP410 . Notably, in ARPP21 , we identified a new high-effect variant (p.P747L) and confirmed that p.P563L is an ALS-associated variant leading to an aggressive disease course. Beyond new discoveries, our analyses largely recapitulated the known genetic architecture of ALS, identifying risk variants in over 20% of cases and supporting a cumulative oligogenic risk model. These findings highlight new translational targets and show that rare variant analyses capture substantially more genetic risk than common variant genome-wide association studies.


  • Genetic basis of the circle of Willis characteristics in the healthy and intracranial aneurysm population

    by Mark K. Bakker, Phebe J. Groenheide, Iris N. Vos, Qi Chang Lin, Marloes H. A. Nanninga, Alina Guzu, Barbara Paic, Tessa A. Verhoeff, Erwin Bekema, Alexander Teumer, et al.

    Rupture of an intracranial aneurysm (IA) can result in aneurysmal subarachnoid hemorrhage (ASAH), a severe and often fatal form of stroke. The configuration of the intracranial arteries – collectively known as the circle of Willis (CoW) – influences the risk of IA development and rupture. Although CoW variation is known to be heritable, its genetic underpinnings and contribution to IA remain poorly understood. Here, we aimed to investigate the genetic architecture of CoW variation and its potential link with IA. Using a semi-automated detection tool, we characterized the diameters, bifurcation angles, and presence of arterial segments of the CoW in 1078 participants from a population-based cohort and 682 IA patients. Composite traits capturing variation in all CoW characteristics were generated through principal component analysis. We conducted a genome-wide association study (GWAS) on these composite traits and identified four loci with suggestively significant associations. Lead single-nucleotide polymorphisms (SNPs) were located in or near the genes DPYSL2, CSMD3, TRPC6, and PKD1L2. Notably, PKD1L2 is closely related to PKD1, a gene implicated in autosomal dominant polycystic kidney disease, a connective tissue disorder that increases IA susceptibility. We observed statistically significant SNP-based heritability for the second principal component of CoW variation (heritability estimate = 0.95, standard error = 0.25). All lead SNPs demonstrated nominal association (p < 0.05) with multiple CoW characteristics and other vascular traits. Our findings highlight a substantial genetic contribution to CoW morphology and offer new insights into the molecular mechanisms underlying CoW variation and its role in IA pathogenesis.


  • Open Access

    Characterising the motif composition and allele length distribution of ZFHX3 GGC repeat expansions in amyotrophic lateral sclerosis

    by Zoe N. Zussa, Andrew N. Smith, Joke J.F.A van Vugt, Daniel S. O’SHaughnessy, Natalie Grima, Sandrine Chan Moi Fat, Ian P. Blair, Dominic B Rowe, Roger Pamphlett, Garth A Nicolson, et al.

    Background and objectives: A pathogenic GGC repeat expansion in the zinc finger homeobox 3 ( ZFHX3 ) gene, encoding a pure polyglycine tract, is the cause of spinocerebellar ataxia type 4 (SCA4). Intermediate expansions of other SCA loci contribute to the risk of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease involving the progressive loss of motor neurons. There is increasing awareness of the role of short tandem repeat (STR) motif composition and configuration in disease pathogenicity. Given the genetic pleiotropy between ALS and SCA, this study aimed to evaluate whether ZFHX3 GGC expansions were associated with ALS and to characterise repeat motif composition. Methods: ExpansionHunter v5 was used to genotype ZFHX3 GGC repeat sizes in short-read whole genome sequencing data from people with ALS and healthy controls of European ancestry. Repeat sizes were visually inspected using REViewer v2. Repeat motif configurations of Australian ALS cases and healthy controls were manually derived from REViewer images. Receiver operating characteristic (ROC) curve analysis and Youden’s J statistic were performed to find a candidate repeat size threshold for association testing. Fisher’s exact tests were performed to evaluate the associations of repeat size and motif composition with disease status. Results: Analysis of 5,785 people with ALS and 7,982 healthy controls found no association between ZFHX3 GGC repeat expansions and disease risk. Fifty unique repeat motif compositions were identified across 802 people with ALS and 800 healthy controls. Of these, eleven distinct configurations coded a pure polyglycine tract which, when expanded, is canonical to SCA4, though no association with ALS was found. Discussion: Although no association was observed between ZFHX3 GGC repeat expansions and ALS, this study established the dynamic nature of ZFHX3 repeat motif composition and configuration. Unique motif compositions were identified both within and between repeat sizes, including the presence of pure polyglycine repeats. Consideration of repeat motif composition and configuration, in addition to repeat allele length, may be important for assessing neurodegenerative disease risk.